
David Hai Ru Chang MD
Heart Failure & Transplantation
MD/California Heart Center
Join to view full profile
127 S San Vicente BlvdSte 6100Los Angeles, CA 90048
Phone+1 310-423-2077
Dr. Chang is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Cardiovascular Disease, 2006 - 2009
University of California Davis HealthResidency, Internal Medicine, 2002 - 2005
University of California, Irvine, School of MedicineClass of 2002
Certifications & Licensure
CA State Medical License 2003 - 2027
American Board of Internal Medicine Advanced Heart Failure and Transplant Cardiology
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014-2017
Publications & Presentations
PubMed
- 1 citationsImpact and outcomes after desensitization therapy in highly sensitized heart transplant candidates.Rashmi Jain, Andriana Nikolova, Michelle Kittleson, Evan P Kransdorf, David Chang
American Journal of Transplantation. 2026-04-01 - Due to Increased Immune Therapies, Are Sensitized Heart Transplant Recipients at Increased Risk for Malignancies?Masaki Tsuji, Michelle M Kittleson, David H Chang, Evan P Kransdorf, Andriana P Nikolova
Transplant International. 2026-01-01 - 2 citationsThe efficacy of biodegradable polymer everolimus-eluting stents in patients with cardiac allograft vasculopathy.Masaki Tsuji, Michelle M Kittleson, David H Chang, Evan P Kransdorf, Andriana P Nikolova
JHLT Open. 2025-11-01
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: